Vomiting clinical trials
The registry lists 793 studies for Vomiting across more than 10 countries. 99 are recruiting or about to start. 248 of them are mainly about Vomiting (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its 2 narrower conditions too, such as Postoperative Nausea and Vomiting: 1,367 studies, 206 open.
ClinicalTrials.gov finds 1,595 studies for Vomiting. How that becomes 793 here
This page counts the studies the registry files under Vomiting, and those it files under no condition that list Vomitingthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 1,595Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −572Filed under a narrower condition, counted on its own pagePostoperative Nausea and Vomiting 545 · Hyperemesis Gravidarum 25
- −43List Vomiting as a condition, but the registry did not file them under itMost often written as “Cyclic Vomiting Syndrome” (11), “Nausea and Vomiting Caused by Chemotherapy” (4), and “Vomiting Syndrome” (2). The registry filed them under other conditions only, most often Nausea (19) and Familial cyclic vomiting syndrome (15).
- −187Match it another way164 name it in the title, 8 in a keyword, and 15 by a synonym or other text the search reads.
- 793The count on this page24 of them list Vomiting in their own words; the registry filed them under no condition.
Get an email when these change. Save the Vomiting studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Merck Sharp & Dohme LLC (28) · GlaxoSmithKline (22) · M.D. Anderson Cancer Center (14) · Helsinn Healthcare SA (12) · The Hospital for Sick Children (9) · Yonsei University (8) · Cairo University (8) · Indiana University (7)
What is being tested here
Drugs under test in Vomiting studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Olanzapine | 4 | 15 | 29 |
| Aprepitant | 3 | 15 | 60 |
| Ondansetron | 2 | 12 | 56 |
| Fosaprepitant | 2 | 8 | 26 |
| Metoclopramide | 2 | 7 | 19 |
| Propofol | 2 | 0 | 7 |
| Dexmedetomidine | 2 | 1 | 5 |
| Palonosetron | 1 | 10 | 37 |
| Ginger extract | 1 | 2 | 8 |
| Acetaminophen | 1 | 1 | 5 |
Drug classes tested here Antiemetics 10 open · 5-HT3 antagonists 5 open · NK1 receptor antagonists 5 open · Antipsychotics 4 open · Antimuscarinics 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use · Phase 3 · Vanda Pharmaceuticals
- Jan 2027Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer · Phase 3 · Feixue Song
- Mar 2027Antiemetic Fosaprepitant To Remedy Nausea and Vomiting · Phase 3 · Montefiore Medical Center
- Jun 2027Inhaled Isopropyl Alcohol for Treatment of Nausea · Phase 3 · State University of New York at Buffalo
- Oct 2027Domperidone in Treating Patients With Gastrointestinal Disorders · Phase 3 · M.D. Anderson Cancer Center
- Nov 2026Manual Acupuncture for Intradialytic Nausea and Vomiting in Patients Undergoing Hemodialysis · Universitas Indonesia
- Nov 2026QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administration · Qilu Pharmaceutical (Hainan) Co., Ltd.
- Nov 2026Indiana University Gastrointestinal Motility Diagnosis Registry · Indiana University
- Nov 2026Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype · Denver Health and Hospital Authority
- Nov 2026Dexmedetomidine and Propofol for Sedation in Cataract Surgery. · Saint-Joseph University
Who these studies take
Of the 56 Vomiting studies recruiting now, 26 (46%) set no upper age limit and 24 (43%) stop at 75 or younger. 10 (18%) take children under 18. 5 (9%) are for women only and 0 (0%) for men only; 17 (30%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 7 (13%) | 7 (13%) |
| 18 | 48 (86%) | 43 (77%) |
| 30 | 49 (88%) | 44 (79%) |
| 40 | 49 (88%) | 44 (79%) |
| 50 | 47 (84%) | 44 (79%) |
| 65 | 47 (84%) | 44 (79%) |
| 75 | 40 (71%) | 37 (66%) |
| 85 | 30 (54%) | 27 (48%) |
Across all 793 studies, recruiting or not: 46% stop at 75 or younger and 37% at 65; 20% take children; 18% are for women only and 2% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Vomiting studies take
Of 56 phase 3 interventional studies under Vomiting, half reached primary completion within 21 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 4 mo3–14 · 19 studies | — | — |
| Phase 2 | 22 mo13–31 · 41 studies | — | — |
| Phase 3 | 21 mo12–38 · 56 studies | — | 24 mo12–51 · 37 studies |
| Phase 4 | 17 mo8–32 · 41 studies | — | 17 mo8–43 · 31 studies |
| Interventional, no phase | 13 mo6–31 · 134 studies | — | 13 mo6–29 · 131 studies |
| Observational | 26 mo10–63 · 37 studies | — | 33 mo10–63 · 35 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Results posted1
- Aromatherapy in Total Knee ReplacementNov 3, 2026NCT06045078
Newly registered3
- Netupitant/Palonosetron for Prevention of Nausea and Vomiting in Breast Cancer ADC TherapyNov 5, 2026NCT07918079
- Manual Acupuncture for Intradialytic Nausea and Vomiting in Patients Undergoing HemodialysisOct 22, 2026NCT07888777
- HR20013 for the Prevention of Nausea and Vomiting in Patients With Cancer: A Real-World StudyOct 14, 2026NCT07874308
Studies
Recruiting first, then most recently updated. Showing 50 of 793. Browse all 793 → or search them.
- Netupitant/Palonosetron for Prevention of Nausea and Vomiting in Breast Cancer ADC TherapyNot yet recruitingNCT07918079Phase 2
- BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to OndansetronRecruitingNCT04150614Phase 41 country
- Manual Acupuncture for Intradialytic Nausea and Vomiting in Patients Undergoing HemodialysisNot yet recruitingNCT07888777Not applicable1 country
- A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerRecruitingNCT07169851Phase 210 countries
- Ondansetron to Prevent Oral Rehydration Failure in Children With CholeraNot yet recruitingNCT07795060Phase 21 country
- Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy VolunteersRecruitingNCT07681076Phase 41 country
- HR20013 for the Prevention of Nausea and Vomiting in Patients With Cancer: A Real-World StudyRecruitingNCT078743081 country
- A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy AdultsRecruitingNCT07868861Phase 11 country
- Granisetron Use, Blood Pressure, and Nausea and Vomiting During Cesarean Delivery Under Spinal AnesthesiaNot yet recruitingNCT078617371 country
- Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal AnesthesiaRecruitingNCT07740577Phase 41 country
- Chinese Herbal Acupoint Application Combined With Triple Antiemetic Therapy for Prevention of Chemotherapy-Induced Nausea and Vomiting in Breast CancerNot yet recruitingNCT07848984Phase 21 country
- GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast CancerNot yet recruitingNCT07465172Not applicable3 countries
- Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)RecruitingNCT06904235Phase 24 countries
- Inhaled Isopropyl Alcohol for Treatment of NauseaRecruitingNCT05418244Phase 2/31 country
- QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous AdministrationNot yet recruitingNCT07817004Phase 1
- A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and VomitingRecruitingNCT07709897Phase 21 country
- Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung CancerRecruitingNCT07768124Not applicable1 country
- Auricular Acupressure for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic ChemotherapyNot yet recruitingNCT07760766Not applicable1 country
- Acupuncture to Prevent Nausea and Vomiting After Stem Cell TransplantEnrolling by invitationNCT07747194Not applicable1 country
- A COMPARATIVE STUDY BETWEEN OPIOID-FREE GENERAL ANAESTHESIA AND OPIOID-BASED GENERAL ANAESTHESIA ON THE QUALITY OF RECOVERY IN PATIENTS UNDERGOING ELECTIVE LAPAROSCOPIC HYSTRECTOMY: A Randomized TrialNot yet recruitingNCT07739641Not applicable1 country
- Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINVRecruitingNCT07726433Phase 21 country
- Brain-Stomach Circuits in Chronic NauseaRecruitingNCT07276035Not applicable1 country
- Hyperemesis Gravidarum Risk Reduction With MetforminRecruitingNCT07129473Phase 1/21 country
- Evaluating Whether a Nausea Band Reduces Symptoms in Those With Chronic Nausea VomitingRecruitingNCT07720323Not applicable1 country
- Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose CisplatinRecruitingNCT07699276Phase 21 country
- The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy IndividualsEnrolling by invitationNCT07687589Not applicable1 country
- Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and MetoclopramideNot yet recruitingNCT06740812Phase 41 country
- Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic TreatmentRecruitingNCT06543316Not applicable1 country
- Indiana University Gastrointestinal Motility Diagnosis RegistryRecruitingNCT045065931 country
- GI Neuromuscular Pathology Prospective RegistryRecruitingNCT021650591 country
- Indiana University Gastric Electrical Stimulation RegistryEnrolling by invitationNCT050472891 country
- Medical Cannabis Observational Study for Antiemetic Intervention in ChemotherapyNot yet recruitingNCT073749391 country
- Balanced Crystalloid vs Normal Saline in Pediatric Acute GastroenteritisRecruitingNCT076103821 country
- Antiemetic Fosaprepitant To Remedy Nausea and VomitingRecruitingNCT06382012Phase 2/31 country
- Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)RecruitingNCT06464926Not applicable5 countries
- Effect of Guided Imagery on Chemotherapy-related Nausea and VomitingRecruitingNCT06120764Not applicable1 country
- Serious Gaming for Chemotherapy-induced Nausea and VomitingRecruitingNCT05838638Not applicable1 country
- An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HECRecruitingNCT07482891Phase 41 country
- Effect of Foot Reflexology On Chemotherapy Induced Nausea and Vomiting in Breast Cancer PatientsNot yet recruitingNCT07322393Not applicable
- Dexmedetomidine and Propofol for Sedation in Cataract Surgery.RecruitingNCT07556133Not applicable1 country
- Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and VomitingRecruitingNCT07208305Phase 31 country
- A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist UseRecruitingNCT07446439Phase 31 country
- Preoperative Oral Hydration in the Ambulatory Arthroplasty PopulationRecruitingNCT05520593Not applicable1 country
- THE EFFECT OF SURGICAL MASK AND N95 MASK USE ON SURGICAL SMOKE IN OPERATING ROOM NURSESRecruitingNCT07404956Not applicable1 country
- Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic SurgeryNot yet recruitingNCT07371728Phase 41 country
- ERAS-Based Preoperative Nutrition and Fasting in Total Knee ArthroplastyRecruitingNCT07336160Not applicable1 country
- Effect of Cardamom and Peppermint Oils on Chemotherapy-Related Nausea-Vomiting and Food IntakeNot yet recruitingNCT07318779Not applicable1 country
- Chewing Gum Flavors to Reduce Postoperative Nausea and Vomiting After PIPACNot yet recruitingNCT07315412Not applicable1 country
- Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT)Enrolling by invitationNCT07209501Not applicable1 country
- Diagnostic PCR Panel in Children With Acute Gastrointestinal SymptomsNot yet recruitingNCT07280624Not applicable